These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 18307044
21. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. Song I, Kim JH, Kim K, Jin HM, Youn BU, Kim N. FEBS Lett; 2009 Jul 21; 583(14):2435-40. PubMed ID: 19576893 [Abstract] [Full Text] [Related]
22. The mechanism of osteoclast differentiation induced by IL-1. Kim JH, Jin HM, Kim K, Song I, Youn BU, Matsuo K, Kim N. J Immunol; 2009 Aug 01; 183(3):1862-70. PubMed ID: 19587010 [Abstract] [Full Text] [Related]
23. Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway. Chamoux E, Houde N, L'Eriger K, Roux S. J Cell Physiol; 2008 Aug 01; 216(2):536-42. PubMed ID: 18338379 [Abstract] [Full Text] [Related]
29. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Tsai HY, Lin HY, Fong YC, Wu JB, Chen YF, Tsuzuki M, Tang CH. Eur J Pharmacol; 2008 Jun 24; 588(1):124-33. PubMed ID: 18495114 [Abstract] [Full Text] [Related]
30. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling. Yang J, Park OJ, Lee YJ, Jung HM, Woo KM, Choi Y. Eur J Immunol; 2008 Jun 24; 38(6):1598-609. PubMed ID: 18421790 [Abstract] [Full Text] [Related]
32. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide. Liu F, Zhu Z, Mao Y, Liu M, Tang T, Qiu S. Biomaterials; 2009 Mar 24; 30(9):1756-62. PubMed ID: 19118894 [Abstract] [Full Text] [Related]
33. Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis. Knowles HJ, Athanasou NA. J Pathol; 2009 Jun 24; 218(2):256-64. PubMed ID: 19291710 [Abstract] [Full Text] [Related]
34. BCL-XL regulates TNF-alpha-mediated cell death independently of NF-kappaB, FLIP and IAPs. Gozzelino R, Sole C, Llecha N, Segura MF, Moubarak RS, Iglesias-Guimarais V, Perez-Garcia MJ, Reix S, Zhang J, Badiola N, Sanchis D, Rodriguez-Alvarez J, Trullas R, Yuste VJ, Comella JX. Cell Res; 2008 Oct 24; 18(10):1020-36. PubMed ID: 18591962 [Abstract] [Full Text] [Related]
35. Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). Zauli G, Rimondi E, Celeghini C, Milani D, Secchiero P. J Cell Physiol; 2010 Feb 24; 222(2):357-64. PubMed ID: 19877156 [Abstract] [Full Text] [Related]
36. Macrophage inflammatory protein-1 delta: a novel osteoclast stimulating factor secreted by renal cell carcinoma bone metastasis. Kominsky SL, Abdelmagid SM, Doucet M, Brady K, Weber KL. Cancer Res; 2008 Mar 01; 68(5):1261-6. PubMed ID: 18316587 [Abstract] [Full Text] [Related]
38. The effect of sex hormones on bone metabolism of the otic capsule--an overview. Horner KC. Hear Res; 2009 Jun 01; 252(1-2):56-60. PubMed ID: 19121641 [Abstract] [Full Text] [Related]
39. In vitro hepatic differentiation of human umbilical cord blood and bone marrow cells. Jung YJ, Ryu KH, Cho KA, Woo SY, Seoh JY, Cho SJ, Joo SY, Yoo K, Ho-Seoung H. Pediatr Hematol Oncol; 2008 Sep 01; 25(6):481-91. PubMed ID: 18728967 [Abstract] [Full Text] [Related]
40. Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6. Hongming H, Jian H. Leuk Res; 2009 Jan 01; 33(1):115-22. PubMed ID: 18778854 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]